查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1404643

次世代定序市場規模、佔有率、趨勢分析報告：按技術、按產品、按應用、按工作流程、按最終用途、按地區、細分市場預測，2024-2030 年

Next Generation Sequencing Market Size, Share & Trends Analysis Report By Technology (WGS, Targeted Sequencing & Resequencing), By Product (Platform, Consumables), By Application, By Workflow, By End-use, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10個工作天內

價格

次世代定序市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，預計2030年全球次世代定序市場規模將達到312.6億美元，2024-2030年複合年成長率為21.12%。

次世代定序（NGS）是一種平行處理技術，可建立具有可擴展性、超高容量和高速度的全基因組序列。此外，醫療保健產業正逐步將NGS涵蓋醫學檢測研究、篩檢和疾病診斷。它經常用於個人化醫療，以加速藥物研發研究方法。

研究人員積極使用RNA定序、全基因組定序、全EXOME和標靶定序等具有各種潛力的定序技術來獲得全面的樣本分析。與傳統的Sanger定序技術相比，NGS 的 DNA 定序成本更低，通量更高。定序前方案、定序後方案和資料分析的自動化程度的提高預計也將對 NGS 市場產生正面影響。透過基因層級的醫學分析利用新平台進行個人化醫療開發也是一個關鍵因素，預計將在預測期內推動 NGS 的需求。

定序產業的其他主要成長趨勢包括個人化醫療和伴同性診斷的進步、雲端運算和資料整合的進步。此外，隨著基因組和蛋白質組資料的可用性不斷增加，該市場已經出現，在預測期內呈現出具有高潛在價值的成長途徑和機會。全球癌症發生率的增加和先進醫療設施的可用性也推動了市場的成長。根據 GLOBOCAN 2020，2020 年新增癌症患者人數為 1,92,92,789 人，預計 2040 年將增加至 2,88,87,940 人。癌症病例數量的顯著增加預計將促進癌症研究，最終加速 NGS 市場的成長。

NGS 診斷技術具有對病毒基因組進行定序並幫助科學家了解突變的潛力。此外，在 COVID-19 疫情期間，世界各國政府正與企業部門合作，將 NGS 技術作為可行的診斷工具推向市場。 2020 年 6 月，美國食品藥物管理局向 Illumina Inc. 授予緊急使用授權，以首次使用次世代定序技術進行 COVID-19 診斷。用於定性鑑定 SARS-CoV-2 RNA 的 Illumina COVIDSeq 測試已獲得 FDA核准。因此，次世代定序（NGS）技術的使用預計會在大流行期間增加。

次世代定序市場報告亮點

  • 從應用來看，腫瘤學領域的收益佔有率最大，2023年為27.31%。該細分市場的成長在很大程度上歸因於癌症盛行率的增加和定序技術的進步。
  • 由於這些機構基於應用的利用率的增加和腫瘤學研究的增加，預計學術研究領域在預測期內將顯著成長。治療藥物、腫瘤學和基因組研究也在取得進展，導致市場成長。
  • 由於醫療保健基礎設施的廣泛開拓、各國積極採用先進技術以及主要企業的存在，預計亞太地區的市場在預測期內將顯著成長。
  • 2023年，北美市場佔據主導地位，佔有率為49.35%。由於高研發投資和技術先進的醫療保健研究框架的存在，預計該地區 WGS 的發展也將成為預測期內北美 NGS 市場成長的關鍵因素。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 成本結構分析
  • 從使用者觀點分析
    • 消費行為分析
  • 流程成本分析
  • 主要最終用戶名單
    • 按類型
    • 依產品
    • 按美國各州
  • 技術概述
    • 技術時間表
  • COVID-19感染疾病的影響
    • 對供應鏈的影響
    • COVID-19 與 NG 之間的關係
  • 市場趨勢及展望
  • 市場區隔和範圍
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 營商環境分析
    • SWOT 分析；按因素（政治/法律、經濟、技術）
    • 波特五力分析
  • 主要交易及策略聯盟分析
    • 合資企業
    • 併購
    • 許可和合作夥伴關係
    • 技術合作

第4章科技業務分析

  • 次世代定序市場：技術波動分析
  • 標靶定序和定序
  • 全基因組序列測定
  • 全EXOME定序
  • 其他

第5章 產品經營分析

  • 次世代定序市場：產品變異分析
  • 平台
  • 消耗品

第6章 應用業務分析

  • 次世代定序市場：應用變化分析
  • 腫瘤學
    • 診斷和篩檢
    • 研究
  • 臨床研究
    • 感染疾病
    • 特發性疾病
    • 遺傳疾病
    • 非傳染性疾病/其他疾病
  • 生殖健康
    • Nipt
    • Pgt
    • 新生兒基因篩檢
    • 單基因分析
  • Hla 分型/免疫系統監測
  • 宏基因體學、流行病學、藥物研發
  • 農業基因組學與法醫學
  • 消費者基因體學

第7章 工作流程業務分析

  • 次世代定序市場：工作流程變化分析
  • 前序
  • 順序
  • 資料分析

第 8 章最終用途業務分析

  • 次世代定序市場：最終用途變異分析
  • 學術研究
  • 臨床調查
  • 醫院和診所
  • 製藥和生物技術公司
  • 其他

第 9 章次世代定序市場：按產品、技術、應用、工作流程和最終用途的區域估計和趨勢分析

  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲

第10章競爭形勢

  • 公司分類
  • 策略規劃
  • 2023 年公司市場佔有率分析
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
    • Qiagen NV
    • Illumina, Inc.
    • F. Hoffmann-La Roche Ag
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.
    • Pieriandx
    • Oxford Nanopore Technologies Plc
    • Partek Incorporated
    • Eurofins Scientific
    • Dnastar
    • Sophia Genetics.
    • Fabric Genomics, Inc.
    • Laboratory Corporation Of America
    • Syapse, Inc.
    • Personalis, Inc.
    • 10x Genomics
    • Dnanexus, Inc.
    • Centogene NV
    • Invitae Corporation
    • Genedx, Llc
Product Code: 978-1-68038-428-4

Next Generation Sequencing Market Growth & Trends:

The global next generation sequencing market size is expected to reach USD 31.26 billion by 2030, registering a CAGR of 21.12% from 2024 to 2030, according to a new report by Grand View Research, Inc. Next-generation Sequencing (NGS) is a parallel processing technique that can establish the sequence of nucleotides in a whole genome with scalability, ultra-high capacity, and fast speed. Furthermore, in the healthcare industry, NGS is gradually being incorporated into medical laboratory research, screening, and disease diagnoses. In personalized medicine, it has been frequently utilized to accelerate the drug research process.

Different potential sequencing methods such as RNA sequencing, whole-genome sequencing, and whole-exome and targeted sequencing amongst others are prominently used by researchers to get comprehensive sample analysis. When compared to the traditional Sanger sequencing technology, NGS is less expensive and provides higher throughput for DNA sequencing. The growing automation in the pre-sequencing protocols, post-sequencing protocols, and data analysis is also projected to have a positive impact on the NGS market. The utilization of novel platforms for the development of personalized medicine by medical analysis at a genetic level is also a significant factor, which is expected to enhance demand for NGS over the forecast period.

Besides, there are other significant growth trends that are being witnessed in the sequencing industry, such as the development of personalized medicine and companion diagnostics, growing advancements in cloud computing, and data integration. Furthermore, the easy availability of genomic and proteomic data has poised this market to exhibit potentially high-value avenues and opportunities for growth over the forecast period. The market growth is also being fueled by an increase in the global prevalence of cancer and the availability of sophisticated healthcare facilities. As per GLOBOCAN 2020, there have been 1,92,92,789 new cancer cases in 2020, with the number expected to rise to 2,88,87,940 by 2040. Such a substantial rise in the number of cancer cases is estimated to leverage cancer research which will eventually accelerate the NGS market growth.

The NGS diagnostic techniques have the potential to determine a virus's genomic sequence and aid scientists in their understanding of mutations. Furthermore, throughout the COVID-19 epidemic, governments across the globe have been collaborating with the corporate sector to introduce NGS technology to the market as a viable diagnostic tool. The US Food and Drug Administration granted Illumina Inc. a case of emergency use permit for the first COVID-19 diagnostic using the next-generation sequence technique in June 2020. The Illumina COVIDSeq Test for qualitative identification of SARS-CoV-2 RNA has been approved by the FDA. As a result, the usage of next-generation sequencing (NGS) technologies is projected to increase during the pandemic.

Next Generation Sequencing Market Report Highlights:

  • By application, the oncology segment held the largest revenue share of 27.31% in 2023. The segment growth is prominently attributed to increasing in the prevalence of cancer and advancements in sequencing technologies
  • The academic research segment is expected to grow lucratively over the forecast period due to an increase in application-based usage in these institutes and a rise in oncology research. In addition, advancements in R&D for therapeutics, oncology, and genomics research led to the growth of the market
  • In Asia Pacific, the market is expected to grow considerably during the forecast period owing to extensive developments in healthcare infrastructure, the positive approach of respective countries for adoption of advanced technologies, and the presence of key players
  • North America dominated the market with a share of 49.35% in 2023, due to the presence of high R&D investment, and availability of technologically advanced healthcare research framework, the development of WGS in the region is also expected to serve as a critical factor for the growth of the North America NGS market throughout the forecast period

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Scope
    • 1.1.1 Estimates And Forecast Timeline
  • 1.2 Research Methodology
  • 1.3 Information Procurement
    • 1.3.1 Purchased Database
    • 1.3.2 Gvr's Internal Database
    • 1.3.3 Primary Research
    • 1.3.4 Details Of Primary Research
      • 1.3.4.1 Primary Interviews: Statistics
      • 1.3.4.1.1 Geographical Distribution Of Primary Interviews
  • 1.4 Information Or Data Analysis
    • 1.4.1 Data Analysis Models
  • 1.5 Market Formulation & Validation
  • 1.6 Objectives
    • 1.6.1 Objective 1
    • 1.6.2 Objective 2

Chapter 2 Executive Summary

  • 2.1 Market Snapshot
  • 2.2 Segment Snapshot
  • 2.3 Competitive Landscape Snapshot

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related/Ancillary Market Outlook
  • 3.2 Cost Structure Analysis
  • 3.3 User Perspective Analysis
    • 3.3.1 Consumer Behavior Analysis
      • 3.3.1.1 Market Influencer Analysis
  • 3.4 Procedure Cost Analysis
  • 3.5 List Of Key End Users
    • 3.5.1 By Type
    • 3.5.2 By Product
    • 3.5.3 By U.S. State
  • 3.6 Technology Overview
    • 3.6.1 Technology Timeline
  • 3.7 Impact Of Covid-19 Pandemic
    • 3.7.1 Impact On The Supply Chain
    • 3.7.2 Association Of Covid-19 With Ngs
  • 3.8 Market Trends And Outlook
  • 3.9 Market Segmentation And Scope
  • 3.10 Market Dynamics
    • 3.10.1 Market Driver Analysis
      • 3.10.1.1 Exponentially Decreasing Costs For Genetic Sequencing
      • 3.10.1.2 Development Of Companion Diagnostics And Personalized Medicine
      • 3.10.1.3 Rise In Competition Among Prominent Market Entities
      • 3.10.1.4 Rising Clinical Opportunity For Ngs Technology
      • 3.10.1.5 Technological Advancements In Cloud Computing And Data Integration
      • 3.10.1.6 Growing Healthcare Expenditure Supporting Development Of Effective Diagnostic & Therapeutic Procedures For Cancer
      • 3.10.1.7 Increasing Prevalence Of Cancer
    • 3.10.2 Market Restraint Analysis
      • 3.10.2.1 Lack Of Computational Efficiency For Data Management
      • 3.10.2.2 Non-Value-Based Ngs Reimbursement Policy And Regulation Status
      • 3.10.2.3 Challenges Associated With Ngs Implementation
  • 3.11 Business Environment Analysis
    • 3.11.1 Swot Analysis; By Factor (Political & Legal, Economic, And Technological)
    • 3.11.2 Porter's Five Forces Analysis
  • 3.12 Major Deals And Strategic Alliances Analysis
    • 3.12.1 Joint Ventures
    • 3.12.2 Mergers & Acquisitions
    • 3.12.3 Licensing & Partnerships
    • 3.12.4 Technology Collaborations

Chapter 4 Technology Business Analysis

  • 4.1 Next Generation Sequencing Market: Technology Movement Analysis
  • 4.2 Targeted Sequencing & Resequencing
    • 4.2.1 Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.1.1 Dna-Based Targeted Sequencing & Resequencing
      • 4.2.1.1.1 Dna-Based Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 4.2.1.2 Rna-Based Targeted Sequencing & Resequencing
      • 4.2.1.2.1 Rna -Based Targeted Sequencing & Resequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Whole Genome Sequencing
    • 4.3.1 Whole Genome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.4 Whole Exome Sequencing
    • 4.4.1 Whole Exome Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.5 Others
    • 4.5.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Product Business Analysis

  • 5.1 Next Generation Sequencing Market: Product Movement Analysis
  • 5.2 Platforms
    • 5.2.1 Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.1 Sequencing
      • 5.2.1.1.1 Sequencing Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 5.2.1.2 Data Analysis
      • 5.2.1.2.1 Data Analysis Platforms Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Consumables
    • 5.3.1 Consumables Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.2 Sample Preparation
      • 5.3.2.1 Sample Preparation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.3 Target Enrichment
      • 5.3.3.1 Target Enrichment Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 5.3.4 Others
      • 5.3.4.1 Others Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis

  • 6.1 Next Generation Sequencing Market: Application Movement Analysis
  • 6.2 Oncology
    • 6.2.1 Oncology Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.2 Diagnostics & Screening
      • 6.2.2.1 Diagnostics & Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2 Oncology Screening
      • 6.2.2.2.1 Oncology Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.2 Sporadic Cancer Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.2.3 Inherited Cancer Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.3 Companion Diagnostics
      • 6.2.2.3.1 Companion Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.2.2.4 Other Diagnostics
      • 6.2.2.4.1 Other Diagnostics Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.2.3 Research Studies
      • 6.2.3.1 Research Studies Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.3 Clinical Investigation
    • 6.3.1 Clinical Investigation Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.2 Infectious Diseases
      • 6.3.2.1 Infectious Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.3 Idiopathic Diseases
      • 6.3.3.1 Idiopathic Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.4 Inherited Diseases
      • 6.3.4.1 Inherited Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.3.5 Non-Communicable/Other Diseases
      • 6.3.5.1 Non-Communicable/Other Diseases Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.4 Reproductive Health
    • 6.4.1 Reproductive Health Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.2 Nipt
      • 6.4.2.1 Nipt Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.2 Aneuploidy
      • 6.4.2.2.1 Aneuploidy Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 6.4.2.3 Microdeletions
      • 6.4.2.3.1 Microdeletions Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.3 Pgt
      • 6.4.3.1 Pgt Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.4 Newborn Genetic Screening
      • 6.4.4.1 Newborn Genetic Screening Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 6.4.5 Single Gene Analysis
      • 6.4.5.1 Single Gene Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.5 Hla Typing/Immune System Monitoring
    • 6.5.1 Hla Typing/Immune System Monitoring Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.6 Metagenomics, Epidemiology & Drug Development
    • 6.6.1 Metagenomics, Epidemiology & Drug Development Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.7 Agrigenomics & Forensics
    • 6.7.1 Agrigenomics & Forensics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 6.8 Consumer Genomics
    • 6.8.1 Consumer Genomics Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 7 Workflow Business Analysis

  • 7.1 Next Generation Sequencing Market: Workflow Movement Analysis
  • 7.2 Presequencing
    • 7.2.1 Pre-Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.1 Ngs Library Preparation Kits
      • 7.2.1.1.1 Ngs Library Preparation Kits Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.2 Semiautomated Library Preparation
      • 7.2.1.2.1 Semiautomated Library Preparation Market Estimates And Forecast, 2018 - 2030 (USD Million)
      • 7.2.1.3 Automated Library Preparation
      • 7.2.1.3.1 Automated Library Preparation Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Sequencing
    • 7.3.1 Sequencing Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Data Analysis
    • 7.4.1 Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.2 Primary Data Ngs Analysis
      • 7.4.2.1 Primary Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.3 Secondary Data Analysis
      • 7.4.3.1 Secondary Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 7.4.4 Tertiary Data Analysis
      • 7.4.4.1 Tertiary Data Analysis Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 End-Use Business Analysis

  • 8.1 Next Generation Sequencing Market: End-Use Movement Analysis
  • 8.2 Academic Research
    • 8.2.1 Academic Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Clinical Research
    • 8.3.1 Clinical Research Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Hospitals & Clinics
    • 8.4.1 Hospitals & Clinics Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Pharmaceutical & Biotech Entities
    • 8.5.1 Pharmaceutical & Biotech Entities Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Other Users
    • 8.6.1 Other Users Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 9 Next Generation Sequencing Market: Regional Estimates And Trend Analysis, By Product, Technology, Application, Workflow, & End-Use

  • 9.1 North America
    • 9.1.1 North America Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.1.2 U.S.
      • 9.1.2.1 Key Country Dynamics
      • 9.1.2.2 Target Disease Prevalence
      • 9.1.2.3 Competitive Scenario
      • 9.1.2.4 Regulatory Framework
      • 9.1.2.5 Reimbursement Scenario
      • 9.1.2.6 U.S. Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.1.3 Canada
      • 9.1.3.1 Key Country Dynamics
      • 9.1.3.2 Target Disease Prevalence
      • 9.1.3.3 Competitive Scenario
      • 9.1.3.4 Regulatory Framework
      • 9.1.3.5 Reimbursement Scenario
      • 9.1.3.6 Canada Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.2 Europe
    • 9.2.1 Europe Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.2 Uk
      • 9.2.2.1 Key Country Dynamics
      • 9.2.2.2 Target Disease Prevalence
      • 9.2.2.3 Competitive Scenario
      • 9.2.2.4 Regulatory Framework
      • 9.2.2.5 Reimbursement Scenario
      • 9.2.2.6 Uk Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.3 Germany
      • 9.2.3.1 Key Country Dynamics
      • 9.2.3.2 Target Disease Prevalence
      • 9.2.3.3 Competitive Scenario
      • 9.2.3.4 Regulatory Framework
      • 9.2.3.5 Reimbursement Scenario
      • 9.2.3.6 Germany Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.4 France
      • 9.2.4.1 Key Country Dynamics
      • 9.2.4.2 Target Disease Prevalence
      • 9.2.4.3 Competitive Scenario
      • 9.2.4.4 Regulatory Framework
      • 9.2.4.5 Reimbursement Scenario
      • 9.2.4.6 France Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.5 Spain
      • 9.2.5.1 Key Country Dynamics
      • 9.2.5.2 Competitive Scenario
      • 9.2.5.3 Regulatory Framework
      • 9.2.5.4 Reimbursement Scenario
      • 9.2.5.5 Spain Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.6 Italy
      • 9.2.6.1 Key Country Dynamics
      • 9.2.6.2 Target Disease Prevalence
      • 9.2.6.3 Competitive Scenario
      • 9.2.6.4 Regulatory Framework
      • 9.2.6.5 Reimbursement Scenario
      • 9.2.6.6 Italy Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.7 Denmark
      • 9.2.7.1 Key Country Dynamics
      • 9.2.7.2 Target Disease Prevalence
      • 9.2.7.3 Competitive Scenario
      • 9.2.7.4 Regulatory Framework
      • 9.2.7.5 Reimbursement Scenario
      • 9.2.7.6 Denmark Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.8 Sweden
      • 9.2.8.1 Key Country Dynamics
      • 9.2.8.2 Target Disease Prevalence
      • 9.2.8.3 Competitive Scenario
      • 9.2.8.4 Regulatory Framework
      • 9.2.8.5 Reimbursement Scenario
      • 9.2.8.6 Sweden Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.2.9 Norway
      • 9.2.9.1 Key Country Dynamics
      • 9.2.9.2 Target Disease Prevalence
      • 9.2.9.3 Competitive Scenario
      • 9.2.9.4 Regulatory Framework
      • 9.2.9.5 Reimbursement Scenario
      • 9.2.9.6 Norway Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.3 Asia Pacific
    • 9.3.1 Asia Pacific Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.2 Japan
      • 9.3.2.1 Key Country Dynamics
      • 9.3.2.2 Target Disease Prevalence
      • 9.3.2.3 Competitive Scenario
      • 9.3.2.4 Regulatory Framework
      • 9.3.2.5 Reimbursement Scenario
      • 9.3.2.6 Japan Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.3 China
      • 9.3.3.1 Key Country Dynamics
      • 9.3.3.2 Target Disease Prevalence
      • 9.3.3.3 Competitive Scenario
      • 9.3.3.4 Regulatory Framework
      • 9.3.3.5 Reimbursement Scenario
      • 9.3.3.6 China Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.4 India
      • 9.3.4.1 Key Country Dynamics
      • 9.3.4.2 Target Disease Prevalence
      • 9.3.4.3 Competitive Scenario
      • 9.3.4.4 Regulatory Framework
      • 9.3.4.5 Reimbursement Scenario
      • 9.3.4.6 India Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.5 Australia
      • 9.3.5.1 Key Country Dynamics
      • 9.3.5.2 Target Disease Prevalence
      • 9.3.5.3 Competitive Scenario
      • 9.3.5.4 Regulatory Framework
      • 9.3.5.5 Reimbursement Scenario
      • 9.3.5.6 Australia Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.6 Thailand
      • 9.3.6.1 Key Country Dynamics
      • 9.3.6.2 Target Disease Prevalence
      • 9.3.6.3 Competitive Scenario
      • 9.3.6.4 Regulatory Framework
      • 9.3.6.5 Reimbursement Scenario
      • 9.3.6.6 Thailand Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.3.7 South Korea
      • 9.3.7.1 Key Country Dynamics
      • 9.3.7.2 Target Disease Prevalence
      • 9.3.7.3 Competitive Scenario
      • 9.3.7.4 Regulatory Framework
      • 9.3.7.5 Reimbursement Scenario
      • 9.3.7.6 South Korea Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.4 Latin America
    • 9.4.1 Latin America Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.2 Brazil
      • 9.4.2.1 Key Country Dynamics
      • 9.4.2.2 Target Disease Prevalence
      • 9.4.2.3 Competitive Scenario
      • 9.4.2.4 Regulatory Framework
      • 9.4.2.5 Reimbursement Scenario
      • 9.4.2.6 Brazil Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.3 Mexico
      • 9.4.3.1 Key Country Dynamics
      • 9.4.3.2 Target Disease Prevalence
      • 9.4.3.3 Competitive Scenario
      • 9.4.3.4 Regulatory Framework
      • 9.4.3.5 Reimbursement Scenario
      • 9.4.3.6 Mexico Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.4.4 Argentina
      • 9.4.4.1 Key Country Dynamics
      • 9.4.4.2 Target Disease Prevalence
      • 9.4.4.3 Regulatory Framework
      • 9.4.4.4 Reimbursement Scenario
      • 9.4.4.5 Argentina Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 9.5 MEA
    • 9.5.1 MEA Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.2 South Africa
      • 9.5.2.1 Key Country Dynamics
      • 9.5.2.2 Target Disease Prevalence
      • 9.5.2.3 Competitive Scenario
      • 9.5.2.4 Regulatory Framework
      • 9.5.2.5 Reimbursement Scenario
      • 9.5.2.6 South Africa Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.3 Saudi Arabia
      • 9.5.3.1 Key Country Dynamics
      • 9.5.3.2 Target Disease Prevalence
      • 9.5.3.3 Competitive Scenario
      • 9.5.3.4 Regulatory Framework
      • 9.5.3.5 Reimbursement Scenario
      • 9.5.3.6 Saudi Arabia Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.4 UAE
      • 9.5.4.1 Key Country Dynamics
      • 9.5.4.2 Target Disease Prevalence
      • 9.5.4.3 Competitive Scenario
      • 9.5.4.4 Regulatory Framework
      • 9.5.4.5 Reimbursement Scenario
      • 9.5.4.6 UAE Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 9.5.5 Kuwait
      • 9.5.5.1 Key Country Dynamics
      • 9.5.5.2 Target Disease Prevalence
      • 9.5.5.3 Competitive Scenario
      • 9.5.5.4 Regulatory Framework
      • 9.5.5.5 Reimbursement Scenario
      • 9.5.5.6 Kuwait Ngs Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 10 Competitive Landscape

  • 10.1 Company Categorization
  • 10.2 Strategy Mapping
  • 10.3 Company Market Share Analysis, 2023
  • 10.4 Company Profiles
    • 10.4.1 Thermo Fisher Scientific, Inc.
      • 10.4.1.1 Company Overview
      • 10.4.1.2 Life Technologies Corporation
      • 10.4.1.2.1 Company Overview
      • 10.4.1.3 Financial Performance
      • 10.4.1.4 Product Benchmarking
      • 10.4.1.5 Strategic Initiatives
    • 10.4.2 Qiagen N.V.
      • 10.4.2.1 Company Overview
      • 10.4.2.2 Clc Bio
      • 10.4.2.2.1 Company Overview
      • 10.4.2.3 Financial Performance
      • 10.4.2.4 Product Benchmarking
      • 10.4.2.5 Strategic Initiatives
    • 10.4.3 Illumina, Inc.
      • 10.4.3.1 Company Overview
      • 10.4.3.2 Edico Genome
      • 10.4.3.2.1 Company Overview
      • 10.4.3.3 Financial Performance
      • 10.4.3.4 Product Benchmarking
      • 10.4.3.5 Strategic Initiatives
    • 10.4.4 F. Hoffmann-La Roche Ag
      • 10.4.4.1 Company Overview
      • 10.4.4.2 Foundation Medicine
      • 10.4.4.2.1 Company Overview
      • 10.4.4.3 Financial Performance
      • 10.4.4.4 Product Benchmarking
      • 10.4.4.5 Strategic Initiatives
    • 10.4.5 Agilent Technologies, Inc.
      • 10.4.5.1 Company Overview
      • 10.4.5.2 Financial Performance
      • 10.4.5.3 Product Benchmarking
      • 10.4.5.4 Strategic Initiatives
    • 10.4.6 Bio-Rad Laboratories, Inc.
      • 10.4.6.1 Company Overview
      • 10.4.6.2 Gnubio
      • 10.4.6.2.1 Company Overview
      • 10.4.6.3 Financial Performance
      • 10.4.6.4 Product Benchmarking
      • 10.4.6.5 Strategic Initiatives
    • 10.4.7 Pieriandx
      • 10.4.7.1 Company Overview
      • 10.4.7.2 Tute Genomics
      • 10.4.7.2.1 Company Overview
      • 10.4.7.2.2 Knome, Inc.
      • 10.4.7.2.2.1 Company Overview
      • 10.4.7.3 Product Benchmarking
      • 10.4.7.4 Strategic Initiatives
    • 10.4.8 Oxford Nanopore Technologies Plc
      • 10.4.8.1 Company Overview
      • 10.4.8.2 Financial Performance
      • 10.4.8.3 Product Benchmarking
      • 10.4.8.4 Strategic Initiatives
    • 10.4.9 Partek Incorporated
      • 10.4.9.1 Company Overview
      • 10.4.9.2 Product Benchmarking
      • 10.4.9.3 Strategic Initiatives
    • 10.4.10 Eurofins Scientific
      • 10.4.10.1 Company Overview
      • 10.4.10.2 Eurofins Gatc Biotech Gmbh
      • 10.4.10.2.1 Company Overview
      • 10.4.10.3 Financial Performance
      • 10.4.10.4 Product Benchmarking
      • 10.4.10.5 Strategic Initiatives
    • 10.4.11 Dnastar
      • 10.4.11.1 Company Overview
      • 10.4.11.2 Product Benchmarking
      • 10.4.11.3 Strategic Initiatives
    • 10.4.12 Sophia Genetics.
      • 10.4.12.1 Company Overview
      • 10.4.12.2 Financial Performance
      • 10.4.12.3 Product Benchmarking
      • 10.4.12.4 Strategic Initiatives
    • 10.4.13 Fabric Genomics, Inc.
      • 10.4.13.1 Company Overview
      • 10.4.13.2 Financial Performance
      • 10.4.13.3 Product Benchmarking
      • 10.4.13.4 Strategic Initiatives
    • 10.4.14 Laboratory Corporation Of America
      • 10.4.14.1 Company Overview
      • 10.4.14.2 Financial Performance
      • 10.4.14.3 Product Benchmarking
      • 10.4.14.4 Strategic Initiatives
    • 10.4.15 Syapse, Inc.
      • 10.4.15.1 Company Overview
      • 10.4.15.2 Product Benchmarking
      • 10.4.15.3 Strategic Initiatives
    • 10.4.16 Personalis, Inc.
      • 10.4.16.1 Company Overview
      • 10.4.16.2 Financial Performance
      • 10.4.16.3 Product Benchmarking
      • 10.4.16.4 Strategic Initiatives
    • 10.4.17 10x Genomics
      • 10.4.17.1 Company Overview
      • 10.4.17.2 Financial Performance
      • 10.4.17.3 Product Benchmarking
      • 10.4.17.4 Strategic Initiatives
    • 10.4.18 Dnanexus, Inc.
      • 10.4.18.1 Company Overview
      • 10.4.18.2 Product Benchmarking
      • 10.4.18.3 Strategic Initiatives
    • 10.4.19 Centogene N.V.
      • 10.4.19.1 Company Overview
      • 10.4.19.2 Financial Performance
      • 10.4.19.3 Product Benchmarking
      • 10.4.19.4 Strategic Initiatives
    • 10.4.20 Invitae Corporation
      • 10.4.20.1 Company Overview
      • 10.4.20.2 Financial Performance
      • 10.4.20.3 Product Benchmarking
      • 10.4.20.4 Strategic Initiatives
    • 10.4.21 Genedx, Llc
      • 10.4.21.1 Company Overview
      • 10.4.21.2 Financial Performance
      • 10.4.21.3 Product Benchmarking
      • 10.4.21.4 Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Country share estimation
  • Table 4 Healthcare expenditure
  • Table 5 NGS top platforms
  • Table 6 Base pairs sequenced using WGS, WES, and targeted sequencing & resequencing
  • Table 7 Clonal amplification products in the market
  • Table 8 North America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 9 North America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 10 North America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 11 North America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 13 North America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 14 North America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 15 North America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 16 North America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 17 North America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 18 North America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 19 North America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 20 North America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 21 US next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 22 US next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 23 US next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 24 US next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 25 US NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 26 US NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 27 US next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 28 US next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 29 US targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 30 US next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 31 US NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 32 US NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 33 US next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Canada next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 35 Canada next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 36 Canada next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 37 Canada next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 38 Canada NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 39 Canada NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 40 Canada next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 41 Canada next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 42 Canada targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 43 Canada next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 44 Canada NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 45 Canada NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 46 Canada next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Europe next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 48 Europe next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 49 Europe next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 50 Europe next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 51 Europe NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 52 Europe NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 53 Europe next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 54 Europe next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 55 Europe targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 56 Europe next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 57 Europe NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 58 Europe NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 59 Europe next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 60 Germany next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 61 Germany next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 62 Germany next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 63 Germany next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 64 Germany NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 65 Germany NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 66 Germany next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 67 Germany next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 68 Germany targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 69 Germany next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 70 Germany NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 71 Germany NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 72 Germany next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 73 UK next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 74 UK next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 75 UK next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 76 UK next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 77 UK NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 78 UK NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 79 UK next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 80 UK next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 81 UK targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 82 UK next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 83 UK NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 84 UK NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 85 UK next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 86 Spain next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 87 Spain next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 88 Spain next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 89 Spain next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 90 Spain NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 91 Spain NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 92 Spain next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 93 Spain next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 94 Spain targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 95 Spain next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 96 Spain NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 97 Spain NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 98 Spain next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 99 France next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 100 France next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 101 France next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 102 France next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 103 France NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 104 France NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 105 France next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 106 France next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 107 France targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 108 France next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 109 France NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 110 France NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 111 France next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 112 Italy next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 113 Italy next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 114 Italy next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 115 Italy next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 116 Italy NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 117 Italy NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 118 Italy next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 119 Italy next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 120 Italy targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 121 Italy next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 122 Italy NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 123 Italy NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 124 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 125 Italy next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 126 Denmark next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 127 Denmark next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 128 Denmark next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 129 Denmark next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 130 Denmark NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 131 Denmark NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 132 Denmark next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 133 Denmark next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 134 Denmark targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 135 Denmark next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 136 Denmark NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 137 Denmark NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 138 Denmark next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 139 Norway next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 140 Norway next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 141 Norway next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 142 Norway next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 143 Norway NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 144 Norway NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 145 Norway next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 146 Norway next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 147 Norway targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 148 Norway next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 149 Norway NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 150 Norway NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 151 Norway next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 152 Sweden next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 153 Sweden next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 154 Sweden next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 155 Sweden next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 156 Sweden NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 157 Sweden NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 158 Sweden next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 159 Sweden next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 160 Sweden targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 161 Sweden next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 162 Sweden NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 163 Sweden NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 164 Sweden next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 165 Asia Pacific next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 166 Asia Pacific next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 167 Asia Pacific next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 168 Asia Pacific next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 169 Asia Pacific NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 170 Asia Pacific NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 171 Asia Pacific next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 172 Asia Pacific next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 173 Asia Pacific targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 174 Asia Pacific next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 175 Asia Pacific NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 176 Asia Pacific NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 177 Asia Pacific next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 178 Japan next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 179 Japan next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 180 Japan next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 181 Japan next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 182 Japan NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 183 Japan NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 184 Japan next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 185 Japan next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 186 Japan targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 187 Japan next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 188 Japan NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 189 Japan NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 190 Japan next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 191 China next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 192 China next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 193 China next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 194 China next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 195 China NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 196 China NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 197 China next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 198 China next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 199 China targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 200 China next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 201 China NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 202 China NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 203 China next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 204 India next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 205 India next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 206 India next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 207 India next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 208 India NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 209 India NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 210 India next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 211 India next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 212 India targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 213 India next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 214 India NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 215 India NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 216 India next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 217 South Korea next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 218 South Korea next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 219 South Korea next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 220 South Korea next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 221 South Korea NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 222 South Korea NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 223 South Korea next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 224 South Korea next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 225 South Korea targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 226 South Korea next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 227 South Korea NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 228 South Korea NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 229 South Korea next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 230 Australia next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 231 Australia next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 232 Australia next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 233 Australia next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 234 Australia NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 235 Australia NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 236 Australia next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 237 Australia next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 238 Australia targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 239 Australia next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 240 Australia NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 241 Australia NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 242 Australia next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 243 Thailand next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 244 Thailand next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 245 Thailand next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 246 Thailand next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 247 Thailand NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 248 Thailand NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 249 Thailand next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 250 Thailand next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 251 Thailand targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 252 Thailand next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 253 Thailand NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 254 Thailand NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 255 Thailand next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 256 Latin America next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 257 Latin America next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 258 Latin America next generation sequencing for oncology diagnostics & screening market, by application, 2018 - 2030 (USD Million)
  • Table 259 Latin America next generation sequencing for oncology screening market, by application, 2018 - 2030 (USD Million)
  • Table 260 Latin America NGS clinical investigation market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 261 Latin America NGS reproductive health market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 262 Latin America next generation sequencing NIPT market, by application, 2018 - 2030 (USD Million)
  • Table 263 Latin America next generation sequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 264 Latin America targeted sequencing/resequencing market estimates & forecasts, by technology, 2018 - 2030 (USD Million)
  • Table 265 Latin America next generation sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 266 Latin America NGS pre-sequencing market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 267 Latin America NGS data analysis market estimates & forecasts, by workflow, 2018 - 2030 (USD Million)
  • Table 268 Latin America next generation sequencing market estimates & forecasts, by end-use, 2018 - 2030 (USD Million)
  • Table 269 Brazil next generation sequencing market estimates & forecasts, by application, 2018 - 2030 (USD Million)
  • Table 270 Brazil next generation sequencing for oncology market estimates & forecasts, by application, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain-Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 Next Generation Sequencing, Market Segmentation
  • Fig. 8 Market Snapshot, 2023
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 13 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 14 Porter's Five Forces Analysis
  • Fig. 15 Global Next Generation Sequencing Market: Product Movement Analysis
  • Fig. 16 Global Next Generation Sequencing Market, for Platforms, 2018 - 2030 (USD Million)
  • Fig. 17 Global Next Generation Sequencing Market, for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 18 Global Next Generation Sequencing Market, for Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 19 Global Next Generation Sequencing Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 20 Global Next Generation Sequencing Market, for Sample Preparation, 2018 - 2030 (USD Million)
  • Fig. 21 Global Next Generation Sequencing Market, for Target Enrichment, 2018 - 2030 (USD Million)
  • Fig. 22 Global Next Generation Sequencing Market: Application, Movement Analysis
  • Fig. 23 Global Next Generation Sequencing Market, for Oncology, 2018 - 2030 (USD Million)
  • Fig. 24 Global Next Generation Sequencing Market, for Diagnostics & Screening, 2018 - 2030 (USD Million)
  • Fig. 25 Global Next Generation Sequencing Market, for Screening, 2018 - 2030 (USD Million)
  • Fig. 26 Global Next Generation Sequencing Market, for Sporadic Cancer, 2018 - 2030 (USD Million)
  • Fig. 27 Global Next Generation Sequencing Market, for Inherited Cancer, 2018 - 2030 (USD Million)
  • Fig. 28 Global Next Generation Sequencing Market, for Companion Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 29 Global Next Generation Sequencing Market, for Other Diagnostics, 2018 - 2030 (USD Million)
  • Fig. 30 Global Next Generation Sequencing Market, for Research Studies, 2018 - 2030 (USD Million)
  • Fig. 31 Global Next Generation Sequencing Market, for Clinical Investigation, 2018 - 2030 (USD Million)
  • Fig. 32 Global Next Generation Sequencing Market for Infectious Diseases 2018 - 2030 (USD Million)
  • Fig. 33 Global Next Generation Sequencing Market, for Idiopathic Diseases, 2018 - 2030 (USD Million)
  • Fig. 34 Global Next Generation Sequencing Market, for Inherited Diseases, 2018 - 2030 (USD Million)
  • Fig. 35 Global Next Generation Sequencing Market, for Non-Communicable/Other Diseases, 2018 - 2030 (USD Million)
  • Fig. 36 Global Next Generation Sequencing Market, for Reproductive Health, 2018 - 2030 (USD Million)
  • Fig. 37 Global Next Generation Sequencing Market, for NIPT, 2018 - 2030 (USD Million)
  • Fig. 38 Global Next Generation Sequencing Market for Aneuploidy, 2018 - 2030 (USD Million)
  • Fig. 39 Global Next Generation Sequencing Market, for Microdeletions, 2018 - 2030 (USD Million)
  • Fig. 40 Global Next Generation Sequencing Market, for PGT, 2018 - 2030 (USD Million)
  • Fig. 41 Global Next Generation Sequencing Market for Newborn Genetic Screening, 2018 - 2030 (USD Million)
  • Fig. 42 Global Next Generation Sequencing Market, for Single Gene Analysis, 2018 - 2030 (USD Million)
  • Fig. 43 Global Next Generation Sequencing Market, for HLA Typing/Immune System Monitoring, 2018 - 2030 (USD Million)
  • Fig. 44 Global Next Generation Sequencing Market, for Metagenomics, Epidemiology & Drug Development, 2018 - 2030 (USD Million)
  • Fig. 45 Global Next Generation Sequencing Market for Agrigenomics & Forensics, 2018 - 2030 (USD Million)
  • Fig. 46 Global Next Generation Sequencing Market, for Consumer Genomics, 2018 - 2030 (USD Million)
  • Fig. 47 Global Next Generation Sequencing Market: Technology Movement Analysis
  • Fig. 48 Global Next Generation Sequencing Market for Whole Genome Sequencing, 2018 - 2030 (USD Million)
  • Fig. 49 Global Next Generation Sequencing Market, for Whole Exome Sequencing, 2018 - 2030 (USD Million)
  • Fig. 50 Global Next Generation Sequencing Market, for Targeted Sequencing & Resequencing, 2018 - 2030 (USD Million)
  • Fig. 51 Global Next Generation Sequencing Market, for DNA-based, 2018 - 2030 (USD Million)
  • Fig. 52 Global Next Generation Sequencing Market for RNA-based, 2018 - 2030 (USD Million)
  • Fig. 53 Global Next Generation Sequencing Market: Workflow Movement Analysis
  • Fig. 54 Global Next Generation Sequencing Market, for Pre-Sequencing, 2018 - 2030 (USD Million)
  • Fig. 55 Global Next Generation Sequencing Market, for Library Preparation, 2018 - 2030 (USD Million)
  • Fig. 56 Global Next Generation Sequencing Market for NGS Library Preparation Kits, 2018 - 2030 (USD Million)
  • Fig. 57 Global Next Generation Sequencing Market for Semi-automated Library Preparation, 2018 - 2030 (USD Million)
  • Fig. 58 Global Next Generation Sequencing Market for Automated Library Prepartion, 2018 - 2030 (USD Million)
  • Fig. 59 Global Next Generation Sequencing Market for Others, 2018 - 2030 (USD Million)
  • Fig. 60 Global Next Generation Sequencing Market for Sequencing, 2018 - 2030 (USD Million)
  • Fig. 61 Global Next Generation Sequencing Market for NGS Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 62 Global Next Generation Sequencing Market for NGS Primary Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 63 Global Next Generation Sequencing Market for NGS Secondary Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 64 Global Next Generation Sequencing Market for NGS Tertiary Data Analysis, 2018 - 2030 (USD Million)
  • Fig. 65 Global Next Generation Sequencing Market: End-use Movement Analysis
  • Fig. 66 Global Next Generation Sequencing Market for Academic Research, 2018 - 2030 (USD Million)
  • Fig. 67 Global Next Generation Sequencing Market for Clinical Research, 2018 - 2030 (USD Million)
  • Fig. 68 Global Next Generation Sequencing Market for Hospitals & Clinics, 2018 - 2030 (USD Million)
  • Fig. 69 Global Next Generation Sequencing Market for Pharma & Biotech Entities, 2018 - 2030 (USD Million)
  • Fig. 70 Global Next Generation Sequencing Market for Other users, 2018 - 2030 (USD Million)
  • Fig. 71 Regional Marketplace: Key Takeaways Other users
  • Fig. 72 Regional Outlook, 2023 & 2030
  • Fig. 73 Global Next Generation Sequencing Market: Region Movement Analysis
  • Fig. 74 North America Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 75 U.S. Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 76 Canada Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 77 Europe Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 78 Germany Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 79 UK Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 80 France Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 81 Italy Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 82 Spain Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 83 Denmark Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 84 Sweden Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 85 Norway Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 86 Asia Pacific Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 87 Japan Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 88 China Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 89 India Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 90 South Korea Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 91 Australia Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 92 Thailand Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 93 Latin America Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 94 Brazil Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 95 Mexico Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 96 Argentina Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 97 Middle East and Africa Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 98 South Africa Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 99 Saudi Arabia Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 100 UAE Next Generation Sequencing Market, 2018 - 2030 (USD Million)
  • Fig. 101 Kuwait Next Generation Sequencing Market, 2018 - 2030 (USD Million)